In silico laboratory: Tools for similarity-based drug discovery

3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Computational methods that predict and evaluate binding of ligands to receptors implicated in different pathologies have become crucial in modern drug design and discovery. Here, we describe protocols for using the recently developed package of computational tools for similarity-based drug discovery. The ProBiS stand-alone program and web server allow superimposition of protein structures against large protein databases and predict ligands based on detected binding site similarities. GenProBiS allows mapping of human somatic missense mutations related to cancer and non-synonymous single nucleotide polymorphisms and subsequent visual exploration of specific interactions in connection to these mutations. We describe protocols for using LiSiCA, a fast ligand-based virtual screening software that enables easy screening of large databases containing billions of small molecules. Finally, we show the use of BoBER, a web interface that enables user-friendly access to a large database of bioisosteric and scaffold hopping replacements.

Cite

CITATION STYLE

APA

Lešnik, S., & Konc, J. (2020). In silico laboratory: Tools for similarity-based drug discovery. In Methods in Molecular Biology (Vol. 2089, pp. 1–28). Humana Press Inc. https://doi.org/10.1007/978-1-0716-0163-1_1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free